Cited by 68Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model OrganismsSirtuins and Resveratrol in Medicine

Advancements in therapeutic drugs targeting of senescence

Open access
Zhu, Mingsheng, Meng, Ping, Ling, Xian, Zhou, Lili·2020·Therapeutic Advances in Chronic Disease

Abstract

Aging leads to a high burden on society, both medically and economically. Cellular senescence plays an essential role in the initiation of aging and age-related diseases. Recent studies have highlighted the therapeutic value of senescent cell deletion in natural aging and many age-related disorders. However, the therapeutic strategies for manipulating cellular senescence are still at an early stage of development. Among these strategies, therapeutic drugs that target cellular senescence are arguably the most highly anticipated. Many recent studies have demonstrated that a variety of drugs exhibit healthy aging effects. In this review, we summarize different types of drugs promoting healthy aging – such as senolytics, senescence-associated secretory phenotype (SASP) inhibitors, and nutrient signaling regulators – and provide an update on their potential therapeutic merits. Taken together, our review synthesizes recent advancements in the therapeutic potentialities of drugs promoting healthy aging with regard to their clinical implications.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/2040622320964125

Cites

198 of 198 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zhu, M., Meng, P., Ling, X., & Zhou, L.
Affiliations
  • Nanfang Hospital (CN)
  • Southern Medical University (CN)
Corresponding author
Zhou, Lili
Venue
Therapeutic Advances in Chronic Disease
Published
2020-01
Volume
11
Pages
2040622320964125-2040622320964125
ISSN
  • 2040-6223 (ISSN-L)
  • 2040-6231
OpenAlex
W3092656362
Cited by
68
References
198
Citations by year
2026: 9 · 2025: 12 · 2024: 19 · 2023: 7 · 2022: 13 · 2021: 8
FWCI
0.89
Type
journal article
Language
en
Open access
Locations
  • Therapeutic Advances in Chronic Disease (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (91949114, 81722011 and 81521003)
  • National Key Research and Development Project (2019YFC2005000)
  • the Project of Innovation Team of Chronic Kidney Disease with Integrated Traditional Chinese and Western Medicine ( (2019KCXTD014)
  • Guangzhou Regenerative Medicine and Health Guangdong Laboratory (2018GZR110105004)
  • Outstanding Scholar Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory (2018GZR110102004)
Topics
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
Keywords
cellular senescence, senolytics, senescence-associated secretory phenotype, healthy aging, age-related diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review